Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
Clinical trial NCT02156674 · TERMINATED
Trial details
- NCT number
- NCT02156674
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-26
- Primary completion
- 2019-12-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.